STERIS (NYSE:STE) (NYSE: STE) is a leading global provider of infection prevention, contamination control and surgical support products and services. The company designs, manufactures and supports a broad portfolio of sterilization and decontamination equipment, washers, disinfectants and monitoring solutions that are used in healthcare, pharmaceutical, medical device and research facilities. In addition, STERIS offers surgical tables, lights and related instrumentation that support a wide range of surgical and critical care environments.
The company’s product offerings span both equipment and consumables, including steam sterilizers, low-temperature sterilization systems, automated endoscope reprocessors, chemical indicators and biologic monitoring. STERIS also provides comprehensive validation, certification and lifecycle support services to help customers maintain regulatory compliance and optimize instrument uptime. The company’s customer base includes hospitals, outpatient centers, pharmaceutical manufacturers, medical device firms and academic research institutions.
Founded in 1985 and headquartered in Mentor, Ohio, STERIS has grown through both organic development and strategic acquisitions, most notably the 2018 merger with Synergy Health which expanded its presence in Europe and Asia. Today, STERIS operates in more than 100 countries, with manufacturing, research and service facilities in North America, Europe and the Asia-Pacific region. As of 2021, Walter M. Rosebrough Jr. serves as president and chief executive officer, leading a management team focused on innovation, quality and global customer support.
